Adagio Medical enrolls first patient in IDE vCLAS Ultra study
Adagio Medical Holdings (ADGM) announced first-patient highlights from its IDE study evaluating the next-generation vCLAS™ Ultra system for ventricular tachycardia at Banner — University Medical Center Phoenix.
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) said it has highlighted the first patient enrolled in its study evaluating its next-generation vCLAS™ Ultra Ult… catheter ablation technology for the treatment of cardiac arrhythmias.